Video

Dr. Lilenbaum on the Challenges of Integrating Telehealth Services in Lung Cancer

Rogerio C. Lilenbaum, MD, discusses the challenges of integrating telehealth services in lung cancer.

Rogerio C. Lilenbaum, MD, director, Banner MD Anderson Cancer Center, discusses the challenges of integrating telehealth services in lung cancer.

In the era of the coronavirus disease 2019 (COVID-19), telehealth has become a key tool in the continuum of patient care. However, despite best efforts to streamline virtual care before the COVID-19 pandemic, challenges remain in utilizing telehealth to its full potential, says Lilenbaum.

Although many of these hurdles have been overcome over the course of the pandemic, it is not fully understood what role telemedicine will play in cancer care after the pandemic, concludes Lilenbaum.

Related Videos
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.